Category

EN

Notice of The Twentieth Annual General Meeting of Shareholders

By | EN, PR

TAIPEI, Taiwan, May 25, 2019 /PRNewswire/ —

GigaMedia Limited
Incorporated in the Republic of Singapore
Registration No.: 199905474H

REGISTERED OFFICE
80 Robinson Road, #02-00
Singapore 068898

NOTICE IS HEREBY GIVEN that the 20th annual general meeting of the shareholders of GigaMedia Limited (the "Company") will be held on June 28, 2019 at 11 a.m. local time at Flat C, 7/F, Lucky Horse Industrial Building, 64 Tong Mi Road, Mongkok, Kowloon, Hong Kong, for the following purposes:

AS ORDINARY AND SPECIAL BUSINESS

ORDINARY RESOLUTIONS:

To consider and, if thought fit, to pass, with or without modification, the following resolutions which will be proposed as Ordinary Resolutions:

1.     Adoption of audited financial statements

          RESOLVED that the Statement by the Directors, Auditor’s Report and Audited Financial Statements of the Company for the financial year ended December 31, 2018 are received and adopted.
(Resolution 1)

2.     Approval of appointment of auditors

          RESOLVED that Deloitte & Touche and Deloitte & Touche LLP be and are hereby appointed as the independent external auditors of the Company until the next Annual General Meeting and that the Directors be and are hereby authorized to fix their remuneration.
(Resolution 2)

3.     Approval of Directors’ remuneration

          RESOLVED that the remuneration of the Directors is hereby approved in an aggregate amount not exceeding US$350,000 in respect of their professional services to the Company until the conclusion of the next Annual General Meeting of the Company.
(Resolution 3)

4.     Approval for authority to allot and issue shares

          RESOLVED that pursuant to Section 161 of the Companies Act, Chapter 50 of Singapore ("Companies Act"), authority be and is hereby given to the Directors of the Company to:

(1)           (a)           issue ordinary shares in the Company ("Shares") whether by way of rights, bonus or otherwise; and/or

               (b)           make or grant offers, agreements or options (collectively, "Instruments") that might or would require Shares to be issued, including but not limited to the creation and issue of (as well as adjustments to) options, warrants, debentures or other instruments convertible into Shares,

               at any time and upon such terms and conditions and for such purposes and to such persons as the Directors may in their absolute discretion deem fit; and

(2)           notwithstanding that the authority conferred by this Resolution may have ceased to be in force, issue Shares pursuant to any Instrument made or granted by the Directors while this Resolution was in force; and

(3)           unless varied or revoked by the Company in general meeting, such authority conferred on the Directors of the Company shall continue in force:

               (i)             until the conclusion of the next Annual General Meeting of the Company or the date by which the next Annual General Meeting of the Company is required by law to be held whichever is earlier; or

               (ii)            in the case of Shares to be issued in pursuance of the Instruments, made or granted pursuant to this Resolution, until the issuance of such Shares in accordance with the terms of the Instruments.

(Resolution 4)

5.     Approval for share purchase mandate      

          RESOLVED that:

(1)           for the purposes of Sections 76C and 76E of the Companies Act, the exercise by the Directors of the Company of all the powers of the Company to purchase or otherwise acquire issued Shares not exceeding in aggregate the Maximum Limit (as hereafter defined), at such price or prices as may be determined by the Directors from time to time up to the Maximum Price (as hereafter defined), by way of market purchase(s) on The Nasdaq Stock Market ("Nasdaq") or off-market purchase(s) on an equal access scheme(s) as may be determined by the Directors as they see fit, which scheme(s) shall satisfy all the conditions of the Companies Act, and otherwise in accordance with all other laws and regulations and rules of Nasdaq as may for the time being be applicable, be and is hereby authorized and approved generally and unconditionally (the "Share Purchase Mandate");

(2)           unless varied or revoked by the Company in a general meeting, the authority conferred on the Directors of the Company pursuant to the Share Purchase Mandate may be exercised by the Directors at any time and from time to time during the period commencing from the date of the passing of this Resolution and expiring on the earlier of:

               (a)           the date on which the next Annual General Meeting of the Company is held; and

               (b)           the date by which the next Annual General Meeting of the Company is required by law to be held;

(3)           in this Resolution:

          "Average Closing Price" means the average of the last dealt prices of a Share for the five consecutive trading days on which the Shares are transacted on Nasdaq immediately preceding the date of market purchase by the Company or the date of making the offer pursuant to an equal access scheme and deemed to be adjusted in accordance with the listing rules of Nasdaq for any corporate action which occurs after the relevant five day period;

          "Maximum Limit" means that number of issued Shares representing 10% of the total number of issued Shares as at the date of the passing of this Resolution (excluding any Shares which are held as treasury shares as at that date); and

          "Maximum Price", in relation to a Share to be purchased or acquired pursuant to the Share Purchase Mandate, means the purchase price (excluding brokerage, commission, applicable goods and services tax and other related expenses) which shall not exceed 105% of the Average Closing Price of the Shares; and

(4)            the Directors of the Company and/or any of them be and are hereby authorized to complete and do all such acts and things (including executing such documents as may be required) as they and/or he may consider expedient or necessary to give effect to the transactions contemplated and/or authorized by this Resolution.

(Resolution 5)

6.     To transact any other business as may properly be transacted at an Annual General Meeting of the Company.

NOTES:

1.     Shareholders are cordially invited to attend the Twentieth Annual General Meeting in person.  Whether or not you plan to be at the Twentieth Annual General Meeting, you are urged to return your proxy.  A shareholder entitled to attend and vote is entitled to appoint one or more proxies to attend and to vote instead of him.

2.     Shareholders wishing to vote by proxy should complete the attached form.

3.     The proxy form of an individual shareholder shall be signed either by the shareholder personally or by his attorney. The proxy form of a corporate shareholder shall be given either under its common seal or signed on its behalf by an attorney or a duly authorized officer of the corporate shareholder.

4.     A proxy need not be a shareholder of the Company.

5.     The proxy form (and if relevant, the original power of attorney, or other authority under which it is signed or a notarially certified copy of such power or authority) must be deposited at Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, or the office of the Company, 8F, No. 22, Lane 407, Section 2, Tiding Boulevard, Taipei 114, Taiwan R.O.C., not less than 48 hours before the time for holding the Twentieth Annual General Meeting, that is by no later than 11 p.m. June 25, 2019 (New York time), or 11 a.m. June 26, 2019 (Taipei time), failing which the proxy shall not be treated as valid.

6.     Electronic Delivery of Future Proxy Materials.  Shareholders can consent to receiving all future proxy statements, proxy card and annual reports electronically via e-mail or the internet. To sign up for electronic delivery, please follow the instructions below relating to "Electronic Delivery of Future Proxy Materials" and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

7.       Only shareholders of record at the close of business on April 26, 2019 are entitled to notice of and to vote at the Twentieth Annual General Meeting, or any adjournment or postponement of the Twentieth Annual General Meeting.

8.     The Company intends to use internal sources of funds or external borrowings or a combination of both to finance the Company’s purchase or acquisition of the Shares pursuant to the Share Purchase Mandate.  The Directors do not propose to exercise the Share Purchase Mandate to such extent that it would materially and adversely affect the financial position of the Company and its subsidiaries.  The amount of financing required for the Company to purchase or acquire its Shares, and the impact on the Company’s financial position, cannot be ascertained as at the date of this Notice as this will depend on the number of Shares purchased or acquired, the price at which such Shares were purchased or acquired and whether the Shares purchased or acquired would be held in treasury or cancelled.

 

BY ORDER OF THE BOARD

 

/s/ Cheng-Ming Huang
………………………………………..
Cheng-Ming Huang (aka James Huang)
Chairman of the Board and Chief Executive Officer

 

TABLE OF CONTENTS

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

PROXY STATEMENT

                Questions and Answers about the Annual Meeting and Voting
                Proposal 1
                Proposal 2
                Proposal 3
                Proposal 4
                Proposal 5           

                Other Matters
                Proxy Solicitation

 

 

 

GigaMedia Limited
Incorporated in the Republic of Singapore
Registration No.: 199905474H

REGISTERED OFFICE
80 Robinson Road, #02-00
Singapore 068898

—————————————————–
PROXY STATEMENT
—————————————————–

QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND VOTING

Why Did I Receive This Proxy Statement?

          We sent you this proxy statement and the enclosed proxy card because the Company’s Board of Directors is soliciting your proxy to be used at the Company’s annual meeting of shareholders on June 28, 2019 at Flat C, 7/F, Lucky Horse Industrial Building, 64 Tong Mi Road, Mongkok, Kowloon, Hong Kong, or at any adjournment or postponement of the meeting. 

Who Can Vote?

          You are entitled to vote if you owned the Shares on the record date ("Record Date"), which is the close of business on April 26, 2019.  Each Share that you own entitles you to one vote.

How Many Shares of Voting Stock Are Outstanding?

          On the Record Date, there were 11,052,235 Shares outstanding.  The Shares are our only class of voting stock.

What May I Vote On?

1. Adoption of Audited Financial Statements
2. Approval of Appointment of Auditors
3. Approval of Directors’ Remuneration
4. Approval for Authority to Allot and Issue Shares
5. Approval for Share Purchase Mandate

Other Business

How Do I Vote?

          To vote by proxy, you should complete, sign and date the enclosed proxy card and return it promptly in the prepaid envelope provided.

Electronic Delivery of Future Proxy Materials

          If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the internet. To sign up for electronic delivery, please go to www.proxyvote.com to indicate that you agree to receive or access proxy materials electronically in future years.

May I Revoke My Proxy?

          Your proxy may be revoked prior to its exercise by appropriate notice to the undersigned.

If I Plan To Attend The Meeting, Should I Still Vote By Proxy?

          Whether you plan to attend the meeting or not, we urge you to vote by proxy.  Returning the proxy card will not affect your right to attend the meeting, and your proxy will not be used if you are personally present at the meeting and inform the Secretary in writing prior to the voting that you wish to vote your Shares in person.

How Will My Proxy Get Voted?

          If you properly fill in your proxy card and send it to us, your proxy holder (the individual named on your proxy card) will vote your Shares as you have directed.  If you sign the proxy card but do not make specific choices, the proxy holder will vote your Shares as recommended by the Board of Directors and the Company’s management.

How Will Voting On Any Other Business Be Conducted?

          Although we do not know of any business to be considered at the meeting other than the proposals described in this proxy statement, if any other business is presented at the meeting, your returned proxy gives authority to the proxy holder to vote on these matters in his discretion.

Proposal 1.            ADOPTION OF AUDITED FINANCIAL STATEMENTS

          The Company seeks shareholders’ adoption of the audited financial statements of the Company (the "Audited Financial Statements"), which have been prepared under Financial Reporting Standards in Singapore ("FRSs") , in respect of the financial year ended December 31, 2018. Along with the Audited Financial Statements, the Company seeks Shareholders’ adoption of the  Statement by the Directors and Auditor’s Report of the Company in respect of the same financial year.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the Twentieth Annual General Meeting of the Company ("AGM").

          The Board of Directors of the Company (the "Board of Directors") recommends a vote FOR this proposal.

Proposal 2.            APPROVAL OF APPOINTMENT OF AUDITORS

          The Company seeks Shareholders’ approval for the appointment of Deloitte & Touche and Deloitte & Touche LLP as the independent external auditors of the Company to hold such office until the conclusion of the next Annual General Meeting of the Company. The Board of Directors also seeks shareholders’ approval to authorize the Board of Directors to fix the remuneration for Deloitte & Touche and Deloitte & Touche LLP in respect of their service to the Company for the financial year ended December 31, 2019.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

Proposal 3.            APPROVAL OF DIRECTORS’ REMUNERATION

          The Company seeks shareholders’ approval on the remuneration of Directors in an aggregated amount not exceeding US$350,000 in respect of their professional services to the Company until the conclusion of the next Annual General Meeting of the Company.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Company’s management recommends a vote FOR this proposal.

Proposal 4.            APPROVAL FOR AUTHORITY TO ALLOT AND ISSUE SHARES

          The Company is incorporated in Singapore. Under the Companies Act, Chapter 50 of Singapore (the "Companies Act"), the Directors may exercise any power of the Company to issue new Shares only with the prior approval of the shareholders of the Company at a general meeting. Such approval, if granted, is effective from the date of the general meeting at which the approval was given until the date on which the next Annual General Meeting of the Company is held or is required by law to be held, whichever is earlier.

          Shareholders’ approval is sought to give Directors authority to allot and issue new Shares and other instruments convertible into Shares during the period from the Twentieth Annual General Meeting to the earlier of the next Annual General Meeting or the date by which the next Annual General Meeting of the Company is required by law to be held.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

Proposal 5.            APPROVAL FOR SHARE PURCHASE MANDATE

          The approval of the Share Purchase Mandate authorizing the Company to purchase or acquire its Shares would give the Company the flexibility to undertake share purchases or acquisitions at any time, subject to market conditions, during the period when the Share Purchase Mandate is in force.

          In managing the business of the Company and its subsidiaries (the "Group"), the Company’s management strives to increase shareholders’ value by improving, inter alia, the return on equity of the Group. A share purchase by the Company is one of the ways through which the return on equity of the Group may be enhanced.

          A Share purchase is also an available option for the Company to return surplus cash which is in excess of the financial and possible investment needs of the Group to its shareholders. In addition, the Share Purchase Mandate will allow the Company to have greater flexibility over, inter alia, the Company’s share capital structure and its dividend policy. 

          The Company intends to use internal sources of funds or external borrowings or a combination of both to finance the Company’s purchase or acquisition of the Shares pursuant to the Share Purchase Mandate.  The Directors do not propose to exercise the Share Purchase Mandate to such extent that it would materially and adversely affect the financial position of the Group.

          Share repurchase programmes may also help buffer short-term share price volatility and off-set the effects of short-term speculators and investors and, in turn, bolster shareholder confidence and employee morale.

          Adoption of this proposal requires the affirmative vote of a majority of the votes cast by shareholders entitled to vote at the AGM.

          The Board of Directors recommends a vote FOR this proposal.

OTHER MATTERS

          As of the date of this Proxy Statement, the Company does not intend to present and has not been informed that any other person intends to present any business not specified in this Proxy Statement for action at the Twentieth Annual General Meeting.

          Shareholders are urged to sign the enclosed proxy form and to return it promptly in the enclosed envelope. Proxies will be voted in accordance with shareholders’ directions. Signing the proxy form does not affect a shareholder’s right to vote at the Twentieth Annual General Meeting, and the proxy may be revoked prior to its exercise by appropriate notice to the undersigned.

PROXY SOLICITATION

          The Company will pay the cost of preparing and mailing this proxy statement and form of proxy to its shareholders. The Company has retained Mackenzie Partners, Inc. to request banks and brokers to forward copies of these materials to persons for whom they hold Shares and to request authority for execution of the proxies.

 

GIGAMEDIA LIMITED

/s/ Cheng-Ming Huang
………………………………………..
Cheng-Ming Huang (aka James Huang)
Chairman of the Board and Chief Executive Officer

 

Cision View original content:http://www.prnewswire.com/news-releases/notice-of-the-twentieth-annual-general-meeting-of-shareholders-300856867.html

Related Links :

http://www.gigamedia.com

Are you a Corporate Representative of GigaMedia Limited, an investor, or a member of the Business Press?



Gratomic Launches its First Graphene from Gratomic Graphite Derived Product

By | EN, PR

TSX-V: GRAT

TORONTO, May 25, 2019 /PRNewswire/ — Gratomic Inc. ("GRAT" or the "Company") (TSX-V: GRAT) (FRANKFURT:CB81, WKN:A143MR) is pleased to announce its first Graphene from Gratomic Graphite derived product.




Gratomic graphenes derived from Gratomic graphite mined from its Aukum Mine located in Namibia are being used to manufacture Graphene enabled conductive inks and pastes. The inks and pastes (to the best of the Company’s knowledge) are amongst the most conductive carbon inks and pastes currently available within the global market place.

The Gratink product is formulated specifically to meet the needs of the printed flexible electronics and EMI shielding markets. Electromagnetic interference (EMI), sometimes referred to as radio-frequency interference (RFI) is a disturbance generated by an external source that affects an electrical circuit by electromagnetic induction, electrostatic coupling, or conduction.

The Gratink and paste applications based on surface modified nano graphene "enablers" offer a product for market penetration into the information technology sector that is now an important aspect of our everyday life.  

The Gratomic Gratink product delivers a functional print and coat component solution.

Due to a multiple range of potential applications including antennas, RFID tags, transistors, sensors, and wearable electronics, the development of printed conductive inks and coatings for electronic applications is growing rapidly. Currently available conductive inks exploit metal nanoparticles to realize electrical conductivity.

Traditionally, metallic nanoparticles are normally derived from silver, copper and platinum based enablers which can be expensive and easily oxidized.

The Gratink product is designed to fill a gap in both the flexible printed electronics and EMI market space where metallic nanoparticle solutions are unnecessary.

Gratink is initially available to meet customer printing and coating preference specifications for R&D purposes with orders available in one-kilo packages.

Following satisfactory customer preproduction qualification, the products can then be varied so they are suitable for printing and coating in bulk quantities formulated to specification and made available as required in 10’s to 100’s of kilos or tonnes.

Please note – Inks and pastes are prepared for all currently available methods of printing and coating with the exception of ink jet printing.

Sheldon Inwentash Co-CEO of Gratomic commented. "Gratomic is delighted to offer their first product of a planned product range based on the Company’s graphene derived from graphite mined from its Aukum Mine."

Gratink is a collaborative development product formulated in tandem with Perpetuus Carbon Technology Wales UK and Gratomic Inc.

For more information, please visit https://gratomic.ca/sales

Gratomic continues to move its business towards production and as part of its business plan, expects to obtain a National Instrument 43-101 Standards of Disclosure for Mineral Projects technical report to help it ascertain the economics of Aukam.

Presently the Company uses its existing pilot processing facility to produce certain amounts of graphite concentrate from accumulated surface graphite.

Qualified Person

Steve Gray, P.Geo. has reviewed, prepared and approved the scientific and technical information in this press release and is Gratomic Inc’s "Qualified Person" as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

Risk Factors

The Company advises that it has not based its production decision on a feasibility study of mineral reserves, demonstrating economic and technical viability, and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit.

Historically, such projects have a much higher risk of economic and technical failure. There is no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved.

Failure to commence production would have a material adverse impact on the Company’s ability to generate revenue and cash flow to fund operations. Failure to achieve the anticipated production costs would have a material adverse impact on the Company’s cash flow and future profitability.

About Gratomic Inc.

Gratomic is an advanced materials company focused on mine to market commercialization of graphite products most notably high value graphene based components for a range of mass market products. We are collaborating with a leading European manufacturer of graphenes to use Aukam graphite to manufacture graphene products for commercialization on an industrial scale. The company is listed on the TSX Venture Exchange under the symbol GRAT. 

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions.  Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).

visit the website at www.gratomic.ca or contact: Arno Brand, Co-CEO, +1 416-561-4095, E-mail inquiries: [email protected] 

Photo – https://mma.prnewswire.com/media/892192/Gratomic_Gratomic_Launches_its_First_Graphene_from_Gratomic_Grap.jpg 

Related Links :

Home

Are you a Corporate Representative of Gratomic, an investor, or a member of the Business Press?



Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons

By | EN, PR

New Members on Board, the Company’s Major Shareholder Maintains Full Confidence in Future Business Development

HONG KONG, May 24, 2019 /PRNewswire/ — Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announced that, Mr Kam Yuen ("Mr Kam") and Mr Kong Kam Yu ("Mr Kong"), executive directors of the Company, Ms Zheng Ting ("Ms Zheng"), non-executive director, Professor Gu Qiao and Professor Cao Gang, independent non-executive directors, voluntarily resigned due to personal reasons.

Mr Kam has resigned as chairman, chief executive, executive director and one of the authorised representatives of the Company; Mr Kong has resigned as executive director, company secretary and qualified accountant of the Company; Ms Zheng has resigned as one of the authorised representatives of the Company, all with effect from 24 May 2019.

Mr Kam, the founder of the Company, initially established the Company with a single medical devices business and has transformed it into an integrated healthcare enterprise with businesses covering hospital, cells and tissues storage, genetic testing services and medical insurance administration. The board of directors of the Company (the "Board") is regretful to learn of his voluntary resignation and would like to take this opportunity to express sincere gratitude to him for his 18-year outstanding contribution since the Company was listed on the Stock Exchange of Hong Kong Limited in 2001. Mr Kong, Ms Zheng, Professor Gu Qiao and Professor Cao Gang had performed their duties with diligence for more than a decade. The Board also deeply regrets his/her voluntary resignation and would like to thank them for their valuable contributions.

The Board is pleased to announce that all with effect from 24 May 2019, Mr Feng Wen, the Company’s current executive director, has been appointed as chairman of the Company; Mr Leong Kim Chuan, the Company’s current deputy chief financial officer, has been appointed as chief executive and executive director of the Company; Mr Poon Tsz Hang has been appointed as independent non-executive director of the Company. Additionally, the Board will recruit suitable senior professionals who have extensive resources and experiences in the healthcare industry to join the Company’s senior management team and points out that the Company’s business operations will proceed as usual. Mr Kam, the Company’s major shareholder, has also expressed his full confidence in the future business development of the Group.

About Golden Meditech Holdings Limited (SEHK stock code: 00801)

Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market and the hospital market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China’s healthcare industry both through organic growth and strategic expansion.

Related Links :

http://www.goldenmeditech.com

Are you a Corporate Representative of Golden Meditech Holdings Limited, an investor, or a member of the Business Press?



VT Holdings Co., Ltd. (7593, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the Fiscal Year Ended March 31, 2019

By | EN, PR

TOKYO, May 24, 2019 /PRNewswire/ — VT Holdings Co., Ltd. (TOKYO: 7593) is pleased to announce its results for the Fiscal Year Ended March 31, 2019.

Summary of Results

In the core automotive business, domestic results were relatively strong during the fiscal year ended March 31, 2019. These robust results were due in part to the impact of new Honda models. Also, sales of Nissan vehicles equipped with e-POWER were favorable, as were sales of electric vehicles. Overseas, the Company acquired three subsidiaries in Spain and South Africa as operating companies from the previous fiscal year through the second quarter of the period under review and was able to add their sales to consolidated business results. The Group’s total of new and second-hand cars sold in the period under review was 101,646, up 6,487 (6.8%) year on year. Meanwhile, performance remained favorable in the housing-related business as the Company received orders for condominium construction projects. However, performance by three consolidated subsidiaries fell below initial forecasts, causing the financial condition to deteriorate. Accordingly, the Company posted JPY872 million in impairment losses as an extraordinary loss.

During the fiscal year ended March 31, 2019, VT Holdings recorded consolidated net sales of JPY218,634 million (up 8.2% YoY), operating income of JPY6,130 million (down 9.6%), ordinary income of JPY6,385 million (down 29.0%) and profit attributable to owners of parent of JPY2,674 million (down 29.0%).

In the automotive business, sales were JPY209,087 million (up 8.3% YoY), and operating income was JPY5,568 million (down 12.9%).

In the new car segment of the automotive business, the number of new cars sold groupwide domestically and internationally was 45,241 (up 12.9% YoY). Profitability declined, however, as the Company prioritized efforts to bolster unit sales by increasing the number of customers under management, bringing down unit profits on new-vehicle sales.

In the used car segment, the number of second-hand cars sold for the entire Group was 56,405 (up 2.4% YoY), with used car sales and profits rising year on year.

In the service segment of the automotive business, both existing and newly consolidated subsidiaries concentrated on boosting orders for routine and officially mandated checks, repairs and commission revenue. Consequently, although sales were down slightly, income increased. In the rent-a-car segment, sales and income both rose year on year thanks to solid operations at new and existing agencies alike.

Sales in the housing-related business were JPY9,355 million (up 4.7%) YoY), and operating income was JPY918 million (up 24.9%).

In the housing-related business, demand was firm and selling prices soared. Due to a thorough focus on marketing, the Company sold nine newly build condominium buildings containing 288 units, bringing its total number of concluded condominium agreements, including those on condominiums completed in inventory, to 243 (163 in the previous fiscal year), and the number of condominiums transferred to 199 (178 in the previous fiscal year). The condominium construction business was generally favorable, and the Company worked to expand orders for commercial facilities.

In the fiscal year ending March 31, 2020, the Japanese government is planning to raise the consumption tax rate. Domestic automobile sales are likely to see a temporary demand surge ahead of the tax hike, falling off and causing the market to shrink once the higher taxes are in place. These fluctuations make the future difficult to forecast. Nevertheless, the Company will continue to concentrate on expanding new car sales, improving customer satisfaction, improving core sales and profits in the used-car and service segments, and striving to expand operations through M&A. For the fiscal year ending March 31, 2020, the company forecasts consolidated net sales of JPY225.0 billion, operating profit of JPY8.3 billion, profit before tax of JPY8.0 billion and profit attributable to owners of parent of JPY4.7 billion. Consolidated performance forecasts for the fiscal year ending March 31, 2020, are calculated in accordance with IFRS rather than conventional Japanese accounting standards.

For the fiscal year ended March 31, 2019, the Company targeted a consolidated dividend payout ratio of 40%. This figure actually amounted to 87.8%, based on annual dividends per share of JPY20 (including a year-end dividend of JPY10 per share). The Company also plans to award interim and year-end dividends of JPY10 per share for the fiscal year ending March 31, 2020.

VT Holdings Co., Ltd. (7593, First Section, TSE) "Summary of Consolidated Financial Results for the Year Ended March 31, 2019" is available here: http://www.vtholdings.co.jp/eng/index.html

Release Disclaimer

This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please make your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries

Borderless IR Co., Ltd. 
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN TEL: +81-3-4588-6706 [email protected]

Borderless IR specializes in the overseas distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

© Borderless IR Co., Ltd. All rights reserved
Unauthorized reproduction of this release or any of its content is strictly prohibited.

Cision View original content:http://www.prnewswire.com/news-releases/vt-holdings-co-ltd-7593-first-section-tokyo-stock-exchange-overview-of-operating-performance-for-the-fiscal-year-ended-march-31-2019-300856445.html

Are you a Corporate Representative of VT Holdings Co., Ltd., an investor, or a member of the Business Press?



Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the First Three Months Ended March 31, 2019

By | EN, PR

TOKYO, May 24, 2019 /PRNewswire/ — Daiki Axis (TOKYO: 4245) is pleased to announce its results for the three months ended March 31, 2019.

Summary of Results

The Company has formulated a new medium-term management plan, "Make FOUNDATION Plan (Promote ESG)," for the fiscal years ending December 31, 2019 to 2021. The company started off the plan by transitioning to a company with an audit and supervisory committee and introducing an executive officer system. The Company’s main business strategy is to focus on ensuring future revenue and profits through several initiatives. First, in the environmental equipment segment, the Company is bolstering sales overseas and strengthening the management of its recurring-revenue energy service company (ESCO) businesses in the areas of maintenance and water utilities. Second, Daiki Axis is transitioning toward growth businesses in the household equipment-related business segment. Third, in the renewable energy segment the company is working to realize a recycling society and striving to shore up stable revenue and profits.

During the first three months of the fiscal year ending December 31, 2019, the Company generated net sales of JPY9,750 million (up 0.3% YoY), operating income of JPY470 million (up 23.1% YoY), ordinary income of JPY513 million (up 21.4% YoY) and profit attributable to owners of parent of JPY302 million (up 25.3% YoY).

In the environmental equipment segment, sales of wastewater treatment systems were up year on year. Performance in Japan was affected by the posting of sales based on the percentage-of-completion-system for recognizing revenues on large-scale projects and the completion of five projects involving the sale of equipment in the water utilities business (excluding ESCO). Overseas sales rose as the Company made progress in cultivating distributors. Sales also grew year on year in the recurring-revenue energy service company (ESCO) businesses in the areas of maintenance and water utilities. Sales in the environmental equipment segment accordingly amounted to JPY5,668 million (up 17.3% YoY), and segment income (operating income) was JPY556 million (up 33.7% YoY).

Sales and income were both down in the household equipment-related business segment. In construction-related sales, the Company saw few medium-sized or large projects, and sales of retail products through DIY stores were down due to lower sales to existing stores. Also, in the construction of residential machinery the company did not benefit from large scale store construction as it had in the preceding fiscal year. Consequently, segment sales in the household equipment-related business segment came to JPY3,523million (down 19.3% YoY), and segment income (operating income) sales were JPY89 million (down 45.5% YoY).

In the renewable energy segment, sales of electricity from solar power generation rose significantly as the Company steadily commenced electricity sales. In addition, sales of biodiesel fuel were up year on year. The Company posted no sales results for the compact wind generation business. Consequently, segment sales came to JPY114 million (up 184.5% YoY), and segment income (operating income) was JPY22 million (a segment loss [operating loss] of JPY56 million in the same period of the previous year.)

In other segments, construction sales in the engineering business were down year on year in the first quarter. Sales were essentially flat year on year in the household water drinking business. As a result, segment sales were JPY443 million (down 8.6% YoY), and segment income (operating income) was JPY30 million (down 50.9% YoY).

Daiki Axis Co., Ltd. (4245, First Section, TSE) "Summary of Consolidated Financial Results for the Three Months Ended March 31, 2019" is available here:
Summary of Consolidated Financial Results for the Three Months Ended March 31, 2019

Release Disclaimer

This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please you’re your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries
Borderless IR Co., Ltd.
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN
TEL: +81-3-4588-6706
[email protected]b-ir.co.jp

Borderless IR specializes in the global distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

©Borderless IR Co., Ltd. All rights reserved
The content of this release may not be duplicated or reproduced.

Cision View original content:http://www.prnewswire.com/news-releases/daiki-axis-co-ltd-4245-first-section-tokyo-stock-exchange-overview-of-operating-performance-for-the-first-three-months-ended-march-31-2019-300856440.html

Are you a Corporate Representative of Daiki Axis Co., Ltd., an investor, or a member of the Business Press?



111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

By | EN, PR

SHANGHAI, May 24, 2019 /PRNewswire/ — Following 111, Inc.’s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. On May 24, 111 and MSH, a world leader in the design and management of international healthcare solution, announced a strategic partnership aiming to combine resources to establish a comprehensive "diagnosis + medication + payment" Internet pharmaceutical and healthcare service closed-loop system by launching online diagnoses, prescription purchase and delivery, refills, health monitoring, patient management services, and enhance the pharmacy benefit management ("PBM") model.

Currently, the percentage of patients with chronic diseases in China continues to increase rapidly due to factors such as an intensive aging population and environmental pollution. Given the high number of chronically ill patients in China, the need for long term medications, high drug prices, and reliance on physician refills, the "Internet + insurance" model will aim to lessen the burden of chronically ill patients by providing them with a new solution to purchase and refill medications.

According to Dr. Gang Yu, Co-Founder and Executive Chairman of 111, given the diverse geographical nature and online payment restrictions in China’s healthcare system, commercial health insurance plans are becoming an important supplement. To solve the shortage of medical resources and disproportionate distribution, 111’s innovative "Internet + insurance" model will serve to reduce current healthcare pressures and to achieve a win-win among users, insurance providers and our national healthcare system.

Dr. Gang Yu, Co-Founder and Executive Chairman of 111, expressed that, given the diverse geographical nature and online payment restrictions of China’s healthcare system, commercial health insurance plans are becoming an important supplement. To resolve the shortage of medical resources and disproportionate distribution, our innovative "Internet + insurance" model will serve to ameliorate current healthcare pressures and to achieve win-win among users, insurance providers and our national healthcare system.

He further summarized, "For chronical patients, we can deliver the ‘fast refills + end-to-end delivery’ through our closed-loop system, providing a convenient solution to reduce drug expenses while improving patient adherence and overall health. Insurance providers will be able to leverage our big data and advanced technologies to improve cost control, medication compliance efficiency and margin. Our system will also support customized products development, product strategies and precision marketing."

As a leader in China’s Internet pharmaceutical and healthcare industry, 111 has built an integrated online and offline healthcare new retail platform which includes 111’s B2C pharmaceutical platform "1 Drugstore", online medical services internet hospital "1 Clinic", and online wholesale pharmacy "1 Drug Mall". The fully integrated online to offline platform effectively combines patient medical services with drugs, B and C-side clients, and direct sales platform through our innovative T2B2C model. The company aims to build an integrated online and offline healthcare ecosystem to empower doctors, pharmacies, hospitals and clinics, pharmaceutical companies and insurance companies.

Celine Zhang, the founder and CEO of MSH CHINA, said, "111 has developed deep roots in the field of health and Internet medicine for many years, established unique competitive barriers through technological advantages, and improved the accessibility of quality medical services through Internet technology. The cooperation between MSH and 111 will place users at the center, explore the health, medical and insurance needs of middle and high-end consumers based on big data, jointly develop insurance products, and open up an integrated service channel around the ecological closed loop of medical and health services."

About MSH CHINA

Founded in 1974, MSH INTERNATIONAL is a world leader in the design and management of international healthcare solutions. Its four regional headquarters located in Paris, Toronto, Dubai and Shanghai, MSH INTERNATIONAL provides 24/7, round-the-clock assistance in 40 languages for its corporate clients and insured members across 200 countries. As the Asia pacific headquarter of MSH INTERNATIONAL, MSH CHINA has a professional service team consists of 550 staff, over 70 staff of whom have professional medical background. The average tenure of the core team is nearly 8 years. MSH is capable of providing clients with most thoughtful services in Chinese, English, French, Japanese, Korean and Cambodian.

For more information on MSH, please visit http://www.mshasia.com/ 

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s new retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit http://ir.111.com.cn 

For more information, please contact:
111, Inc.
IR Director
Ms. Monica Mu
[email protected] 

Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: [email protected]

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: [email protected] 

Cision View original content:http://www.prnewswire.com/news-releases/111-to-collaborate-with-msh-to-build-internet-pharmaceutical-and-healthcare-service-closed-loop-system-300856555.html

Related Links :

http://ir.111.com.cn

Are you a Corporate Representative of 111, Inc., an investor, or a member of the Business Press?



Urban Tea, Inc. Announces Pricing of Approximately $4.6 Million Registered Direct Offering

By | EN, PR

NEW YORK, May 24, 2019 /PRNewswire/ — Urban Tea, Inc. (the "Company") (NASDAQ: MYT), a premier retailer of specialty teas and baked goods in China, announced today it has entered into a securities purchase agreement with certain institutional investors to purchase approximately $4.6 million worth of its ordinary shares and warrants to purchase ordinary shares in a registered direct offering.

Under the terms of the securities purchase agreement, the Company has agreed to sell 2,845,000 ordinary shares and to issue warrants to purchase up to 1,809,420 ordinary shares. The warrants will be exercisable immediately following the date of issuance for a period of five years at an exercise price of $1.86 per share. The purchase price for one ordinary share and a corresponding warrant will be $1.62. The gross proceeds to the Company from the registered direct offering are estimated to be approximately $4.6 million before deducting the placement agent’s fees and other estimated offering expenses. The registered direct offering is expected to close on or about May 29, 2019, subject to the satisfaction of customary closing conditions.

FT Global Capital, Inc. acted as sole placement agent for the offering.

The offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-227211), previously filed with the Securities and Exchange Commission (the "SEC") on September 6, 2018 and declared effective on September 19, 2018. The securities are being offered only by means of a prospectus supplement pursuant to the Company’s effective shelf registration statement and base prospectus contained therein. A prospectus supplement and the accompanying prospectus relating to and describing the terms of the registered direct offering will be filed with the SEC.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Urban Tea, Inc.

Urban Tea, Inc. is an emerging specialty tea product distributer and retailer headquartered in Changsha City, Hunan Province, China. Through its wholly owned subsidiary, Shanghai Ming Yun Tang Tea Limited ("Shanghai MYT") which controls Hunan Ming Yun Tang Brand Management Co., Ltd. ("Hunan MYT"), the Company currently market a wide range of trendy tea drinks, light meals, and pastries targeting China’s new urban generation in Hunan province. Our products are focused on not only their taste but also their aesthetic presentation and health benefits. Our products are currently being offered via our own stores. We expect to start selling our products in our managed and JV stores in mid-2019. For more information, please visit: ir.h-n-myt.com.

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

For more information, please contact investor relations:       

Tina Xiao
Ascent Investor Relations LLC
Phone: +1-917-609-0333
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/urban-tea-inc-announces-pricing-of-approximately-4-6-million-registered-direct-offering-300856460.html

Related Links :

http://ir.h-n-myt.com

Are you a Corporate Representative of Urban Tea Inc., an investor, or a member of the Business Press?



New Power System with Canadian Solar Modules Helps a Medical Center in Sierra Leone

By | EN, PR

GUELPH, Ontario, May 24, 2019 /PRNewswire/ — Canadian Solar Inc. (NASDAQ: CSIQ), one of the world’s largest solar power companies, announced today that through its module donation, a new solar power system has been successfully energized at the Evans Medical Center at Kirma, Lungi, Sierra Leone.

The charity project was initiated a year ago by Melanie Evans from the ‘Lungi Sierra Leone Charity’ and was realized with Canadian Solar MaxPower CS6U-P 330W solar modules for a 4 KW solar system.

Four other industry partners donated additional equipment, including storage and control systems. SegenSolar (Pty) Ltd. supplied the inverter, charge controller and electrical components. The Schletter Group contributed the mounting system, while Bonus Solar provided batteries, cables and isolators. The installation and commissioning was carried out by Electric Future, who specializes in design and delivery of solar installations. They provided the expertise and manpower along with Canadian Solar to deliver a safe and reliable solution. The solar power system provides the clinic with a sustainable energy source that enables a constant power supply for vaccine refrigerators, a blood bank and many other medical accessories and emergency lighting.

A reliable power supply is a fundamental prerequisite for adequate medical care. The solar system will directly improve the quality of medical care in the region. A new blood bank, which is the first in the Lungi area, will provide patients with vital bloods, where they previously had to rely on a suitable donor and wait for screening. The solar power system not only provides energy for the blood bank but also powers the vaccine refrigerators, fetal monitor and labor ward ultrasound, along with other critical equipment. A constant power supply is required as any power outage would destroy vital bloods and vaccines. Before the solar power system was installed, the Medical Center had to rely on an ageing generator, which would incur prohibitive costs if it operated for 24 hours a day. Now the generator is used as a backup generator.

"The realization of the solar power system for the clinic in Lungi shows how our industry can sustainably improve the situation for newborn babies, children, and the local population in a developing country," said Dr. Shawn Qu, Chairman and Chief Executive Officer of Canadian Solar Inc.

The project is also an example of how different companies from the same industry can consolidate their resources to achieve positive results. 

Sierra Leone is one of the least electrified countries with a nationwide electrification rate of just 5%, and in outlay rural areas this drops to 1% – the use of photovoltaics therefore provides greatly needed electricity.

Today, May 24, 2019, the clinic has its official opening ceremony to thank all donors and staff. The ceremony will be attended by the Vice President of Sierra Leone Mohamed Juldeh Jalloh and other dignitaries including the Ministers of Health and Education.

About Canadian Solar Inc.

Canadian Solar was founded in 2001 in Canada and is one of the world’s largest and foremost solar power companies. It is a leading manufacturer of solar photovoltaic modules and provider of solar energy solutions and has a geographically diversified pipeline of utility-scale power projects in various stages of development. Over the past 18 years, Canadian Solar has successfully delivered over 32 GW of premium quality modules to customers in over 150 countries around the world. Canadian Solar is one of the most bankable companies in the solar industry, having been publicly listed on NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

Canadian Solar’s Safe Harbor/Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "believes," "expects," "anticipates," "intends," "estimates," the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future available supplies of high-purity silicon; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company’s SEC filings, including its annual report on Form 20-F filed on April 25, 2019. Although the Company believes that the expectations reflected in the forward looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

Cision View original content:http://www.prnewswire.com/news-releases/new-power-system-with-canadian-solar-modules-helps-a-medical-center-in-sierra-leone-300856548.html

Related Links :

http://www.canadiansolar.com

Are you a Corporate Representative of Canadian Solar Inc., an investor, or a member of the Business Press?



Global Leaders Call for a New Playbook to Accelerate Progress on Gender Equality at P&G WeSeeEqual Summit

By | EN, PR

  1. Private and Public sector opinion leaders gathered in Singapore to share on dispelling ‘myths’ that hold women back at work and insights on how to level the field with men as allies
  2. Distinguished attendees include former Australia Prime Minister Julia Gillard and UN Women Regional Director for Asia and the Pacific, Mohammad Naciri
  3. The graduation ceremony for the 2019 cohort of P&G and WEConnect Int’l Women Entrepreneurs Development Program, was also held at the summit

SINGAPORE, May 24, 2019 /PRNewswire/ — Procter & Gamble (NYSE:PG) today hosted the second annual Asia Pacific #WeSeeEqual Summit, bringing together eminent figures from private and public sectors to share their point of view on the underrepresentation of women in leadership roles, and call out on the need as leaders to impact change and accelerate progress for gender equality.

This year, the focus of the #WeSeeEqual discussion centered on leaders’ key role in changing the narrative about women by challenging the assumptions that still exist — "myths" around women’s leadership skills, their representation in science, technology, engineering and mathematics (STEM), or their ambitions — and creating a new playbook that goes beyond re-writing talent systems, driving equality-based policies and practices, to broadening  the current definition of leadership through the attention and action of both women and men alike.

The long-day program saw the participation of  illustrious speakers, influential personalities and leaders from around the world, including Julia Gillard, former Prime Minister of Australia, Mohammad Naciri, UN Women Regional Director for Asia and the Pacific, Tiffany Dufu, author of Drop the Ball: Achieving More By Doing Less, Pocket Sun, Co-Founder and Managing Partner of SoGal Ventures, P&G executives and gender equality advocates Magesvaran Suranjan, P&G President, APAC and IMEA, Karl Preissner, P&G Leader, Global Diversity and Inclusion, and Balaka Niyazee, P&G VP of  Korea and Executive Sponsor, Gender Diversity, APAC.

Balaka Niyazee, Vice President, P&G Korea, and Gender Equality Sponsor officiated the P&G APAC #WeSeeEqual Summit 2019 with a powerful speech on gender myths.


Balaka Niyazee, Vice President, P&G Korea, and Gender Equality Sponsor officiated the P&G APAC #WeSeeEqual Summit 2019 with a powerful speech on gender myths.

Opening the session, Magesvaran Suranjan, said, "As a leader, it is imperative that we write a new playbook for a gender equal workplace and world. At P&G, I am proud that we have always been a strong advocate for gender equality and, today, we have a significant number of women in leadership positions in APAC and around the world. Gender equality goes beyond targets, quotas and sponsorship of women’s development programs. We need new interventions to "Fix the System" and include men as inclusive and equality-minded leaders. The focus is on workplaces where men champion equality together with women. When more corporations and organizations commit to championing equality, then we will see equal."

Magesvaran Suranjan, President, P&G Asia Pacific and Indian Subcontinent, Middle East and Africa, making his opening remarks at the P&G APAC #WeSeeEqual Summit 2019.


Magesvaran Suranjan, President, P&G Asia Pacific and Indian Subcontinent, Middle East and Africa, making his opening remarks at the P&G APAC #WeSeeEqual Summit 2019.

Julia Gillard, who made history as the first female Prime Minister of Australia, says, "I am very pleased and honoured to support the gender equality commitment by P&G APAC to strengthen success for women in business and life.  I believe the WeSeeEqual movement is a force for change and progress towards gender equity and stronger communities."

To encourage and inspire more men in their support of gender equality, the #WeSeeEqual Summit hosted male allies, including Ralph Haupter, President of Microsoft Asia and Tsuyoshi Morioka, CEO, Katana Inc to share their experiences in overcoming bias, spearheading greater diversity and equality, and being equal partners in the workplace and at home.

Mohammad Naciri, UN Women Regional Director for Asia and the Pacific, says, "Gender equality is not only the right thing to do, it is the smart thing to do. We know when equality increases economies and communities do better. In order to achieve a more gender-equal society, the corporate sector plays a crucial role alongside governments and civil society in implementing policies and initiatives that support women. This is not a women’s-only fight, but men, too, must play an active role in advocating for inclusivity and change."

The various panel sessions covered gender equality in its many facets, including the importance of women’s economic empowerment to reach to the UN Sustainable Development Goal (SGD) on Gender Equality, the role of advertising and media in changing bias, the benefits of professional and personal support groups in positively impacting work-life balance, and the importance of a new narrative with a broader definition of leadership that is not limited to the male leadership prototype.

As a flagship event that highlights P&G’s continued commitment to lead the change in gender equality both within the organization and outside in the community, the 2019 #WeSeeEqual Summit also hosted a milestone event for select women entrepreneurs in Singapore as they celebrated their graduation from P&G and WEConnect International Women Entrepreneurs Development Program. The ten-course capability training program, is part of P&G’s long-term commitment to support women’s economic empowerment by promoting a more diverse supply network under the global initiative ‘Supplier Diversity Program’ and ensure local businesses, especially those owned and led by women, are a growing part of P&G’s partner ecosystem and global value chain.

Please click on this link for more event photos in high-resolution: here

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

Photo – https://photos.prnasia.com/prnh/20190524/2476538-1-a
Photo – https://photos.prnasia.com/prnh/20190524/2476538-1-b

Related Links :

www.pg.com

Are you a Corporate Representative of Procter & Gamble, an investor, or a member of the Business Press?



JMU Receives Notification of Deficiency From Nasdaq Relating to Delayed Filing of Annual Report on Form 20-F

By | EN, PR

SHANGHAI, May 24, 2019 /PRNewswire/ — JMU Limited (the "Company" or "JMU") (NASDAQ: JMU), a B2B online e-commerce platform that provides integrated services to suppliers and customers in the foodservice industry in China, today announced it has received a notice from Nasdaq stating that, as a result of not having timely filed its annual report on Form 20-F for the year ended December 31, 2018, JMU is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "Commission").

The Company is required by Nasdaq to submit its plan to regain compliance no later than May 31, 2019. If the plan is accepted by Nasdaq, the Company can be granted up to 180 calendar days from the Form 20-F’s due date, or until November 11, 2019, to regain compliance.

On April 30, 2019, the Company filed a Notification of inability to timely file Form 20-F on Form 12b-25 due to the Company’s need for additional time to finalize Form 20-F due to the change of Company’s independent auditor.

JMU continues to work diligently to complete the Form 20-F and file it with the Commission as soon as reasonably practicable. The Company expects to submit a plan to regain compliance or file its Form 20-F within the timeline prescribed by Nasdaq.

In addition, Nasdaq is requesting information regarding changes to the Company’s independent auditor, which the Company announced in a press release dated April 9, 2019.

About JMU Limited

JMU Limited is a B2B e-commerce platform that provides integrated services to suppliers and customers in the foodservice industry in China. For more information, please visit: http://ir.ccjmu.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbour" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "aim," "anticipate," "believe," "estimate," "expect," "going forward," "intend," "ought to," "plan," "project," "potential," "seek," "may," "might," "can," "could," "will," "would," "shall," "should," "is likely to," and the negative form of these words and other similar expressions. Among other things, statements that are not historical facts, including statements about JMU’s beliefs and expectations, the business outlook and quotations from management in this announcement, as well as JMU’s strategic and operational plans, are or contain forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: The general economic and business conditions in China may deteriorate. The growth of Internet and mobile user population in China might not be as strong as expected. JMU’s plan to enhance customer experience, upgrade infrastructure and increase service offerings might not be well received. JMU might not be able to implement all of its strategic plans as expected. Competition in China may intensify further. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and JMU does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Contact:

Zhengzhen Li
JMU Limited
[email protected]
Tel: +86 (021) 6015-1166, ext. 8904

Cision View original content:http://www.prnewswire.com/news-releases/jmu-receives-notification-of-deficiency-from-nasdaq-relating-to-delayed-filing-of-annual-report-on-form-20-f-300856446.html

Related Links :

http://ir.ccjmu.com

Are you a Corporate Representative of JMU Ltd, an investor, or a member of the Business Press?